PetMed Express, Inc. (PETS) News
Track canonical SquawkNews coverage tagged to PETS, PetMed Express, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 6 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
PetMeds (PETS) reports first-quarter financial results
PetMeds® announces its first quarter financial results, as reported by the TradeXchange Newsdesk.
EARNINGS | Aug 13, 2026, 08:07 PM UTC
L
PETS - PetMed Express, Inc. to Report First Quarter Fiscal Year 2027 Financial Results on Thursday, August 13, 2026
PETS - PetMed Express, Inc. to Report First Quarter Fiscal Year 2027 Financial Results on Thursday, August 13, 2026
EARNINGS | Jul 30, 2026, 12:02 PM UTC
L
PetMed Express shares are trading higher. The company confirmed its Board has received an unsolicited, non-binding, and conditional acquisit
PetMed Express shares are trading higher. The company confirmed its Board has received an unsolicited, non-binding, and conditional acquisition proposal from SilverCape for $3.00 per share in cash.
MNA | Jun 30, 2026, 05:33 PM UTC
L
PetMed Express Board Confirms Proposed $3/Share Acquisition Offer From SilverCape Investments
PetMed Express, Inc. ("PetMeds" or the "Company") (NASDAQ: PETS ) today confirmed that its Board of Directors (the "Board") has received an unsolicited, non-binding, and conditional proposal from SilverCape Investments L
MNA | Jun 30, 2026, 01:16 PM UTC
M
Activist Investor Slams PetMed Board For 'Stunning Destruction' Of Shareholder Value
PetMed Express, Inc. (NASDAQ: PETS ) stock is trading higher on Monday following the public release of a revised acquisition proposal from SilverCape Investments Limited. Revised Acquisition Proposal Details For PetMed E
MNA | Jun 29, 2026, 04:23 PM UTC
M
SilverCape Investments Revises Acquisition Proposal For PetMed Express To $3.00 Per Share In Cash With No Financing Contingency; Seeks PETS
The proposed purchase price represents a premium of approximately 70% to PetMed’s closing share price of $1.76 on June 26, 2026. In its letter to the Board, SilverCape outlines its belief that: Based upon the dismal quar
MNA | Jun 29, 2026, 11:12 AM UTC